Patient who showed marked clinical improvement in his psoriasis (72 percent improvement in PASI) after treatment with the galectin-3 inhibitor GR-MD-02
Patient who showed marked clinical improvement in his psoriasis (72 percent improvement in PASI) after treatment with the galectin-3 inhibitor GR-MD-02